These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes. Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451 [TBL] [Abstract][Full Text] [Related]
4. A simple high-performance liquid chromatographic method for the measurement of 2-methylsulfonylpyridine in plasma. Jasheway DW; Park YH; Mayer PR J Anal Toxicol; 1990; 14(1):54-7. PubMed ID: 2314064 [TBL] [Abstract][Full Text] [Related]
5. [Studies on pharmacokinetics and biotransformation of reproterol in animal and man (author's transl)]. Niebch G; Obermeier K; Vergin H; Thiemer K Arzneimittelforschung; 1977; 27(12):37-45. PubMed ID: 576829 [TBL] [Abstract][Full Text] [Related]
6. The biotransformation of fluproquazone in man and several animal species. Orwig BA; Dugger HA; Bhuta SI; Talbot KC; Schwarz HJ Arzneimittelforschung; 1981; 31(5a):904-11. PubMed ID: 6973984 [TBL] [Abstract][Full Text] [Related]
7. Biotransformation of zeranol: disposition and metabolism in the female rat, rabbit, dog, monkey and man. Migdalof BH; Dugger HA; Heider JG; Coombs RA; Terry MK Xenobiotica; 1983 Apr; 13(4):209-21. PubMed ID: 6624136 [TBL] [Abstract][Full Text] [Related]
8. Species differences in the formation of vabicaserin carbamoyl glucuronide. Tong Z; Chandrasekaran A; DeMaio W; Jordan R; Li H; Moore R; Poola N; Burghart P; Hultin T; Scatina J Drug Metab Dispos; 2010 Apr; 38(4):581-90. PubMed ID: 20032194 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey. Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of YM928, a novel noncompetitive AMPA receptor antagonist, and its demethylated metabolite in rat, dog and monkey plasma by high-performance liquid chromatography with ultraviolet detection. Kato K; Noguchi K; Aoki T; Soeishi Y; Kamimura H Biomed Chromatogr; 2006 Dec; 20(12):1328-35. PubMed ID: 16977590 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species. Monbaliu J; Verhaeghe T; Willems B; Bode W; Lavrijsen K; Meuldermans W Arzneimittelforschung; 2003; 53(7):486-95. PubMed ID: 12918214 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. Klotz U; Antonin KH; Bieck PR J Pharmacol Exp Ther; 1976 Oct; 199(1):67-73. PubMed ID: 789856 [TBL] [Abstract][Full Text] [Related]
13. Biotransformation of nimodipine in rat, dog, and monkey. Scherling D; Bühner K; Krause HP; Karl W; Wünsche C Arzneimittelforschung; 1991 Apr; 41(4):392-8. PubMed ID: 1859512 [TBL] [Abstract][Full Text] [Related]
14. The biotransformation of the ergot derivative CQA 206-291 in human, dog, and rat liver slice cultures and prediction of in vivo plasma clearance. Vickers AE; Connors S; Zollinger M; Biggi WA; Larrauri A; Vogelaar JP; Brendel K Drug Metab Dispos; 1993; 21(3):454-9. PubMed ID: 8100501 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogs. Ericsson H; Tholander B; Björkman JA; Nordlander M; Regårdh CG Drug Metab Dispos; 1999 May; 27(5):558-64. PubMed ID: 10220482 [TBL] [Abstract][Full Text] [Related]
16. [Ambroxol, comparative studies of pharmacokinetics and biotransformation in rat, rabbit, dog and man (author's transl)]. Hammer R; Bozler G; Jauch R; Koss FW; Hadamovsky H Arzneimittelforschung; 1978; 28(5a):899-903. PubMed ID: 581988 [TBL] [Abstract][Full Text] [Related]
17. Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane. Lu Y; Rieth S; Lohitnavy M; Dennison J; El-Masri H; Barton HA; Bruckner J; Yang RS Regul Toxicol Pharmacol; 2008 Mar; 50(2):249-60. PubMed ID: 18226845 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tissue residues of hydrochloric acid albendazole sulfoxide and its metabolites in crucian carp (Carassius auratus) after oral administration. Li Z; Chen C; Ai D; Wang C; Li J; Qi Y; Yi W; Shen H; Cao J Environ Toxicol Pharmacol; 2012 Mar; 33(2):197-204. PubMed ID: 22227164 [TBL] [Abstract][Full Text] [Related]
19. Kinetics, distribution, and biotransformation of the chemical HI-6 in the rat, dog, and rhesus monkey. Ecobichon DJ; Comeau AM; O'Neil WM; Marshall WD Can J Physiol Pharmacol; 1990 May; 68(5):614-21. PubMed ID: 2340450 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man. Eckert HG; Badian MJ; Gantz D; Kellner HM; Volz M Arzneimittelforschung; 1984; 34(10B):1435-47. PubMed ID: 6097271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]